Investors Catching Stocks Atara Biotherapeutics, Inc.(NASDAQ:ATRA): CenturyLink, Inc.(NYSE:CTL)

0
5

Atara Biotherapeutics, Inc. (ATRA) will report its next earnings on Nov 07 BMO. The company reported the earnings of $-1.31/Share in the last quarter where the estimated EPS by analysts was $-1.44/share. The difference between the expected and actual EPS was $0.13/share, which represents an Earnings surprise of 9%.

Many analysts are providing their Estimated Earnings analysis for Atara Biotherapeutics, Inc. and for the current quarter 9 analysts have projected that the stock could give an Average Earnings estimate of $-1.34/share. These analysts have also projected a Low Estimate of $-1.56/share and a High Estimate of $-1.27/share.

These analysts also forecasted Growth Estimates for the Current Quarter for ATRA to be 26.3%. They are projecting Next Quarter growth of 8.33%. For the next 5 years, Atara Biotherapeutics, Inc. is expecting Growth of 12.73% per annum, whereas in the past 5 years the growth was -3.42% per annum.

Some buy side analysts are also providing their Analysis on Atara Biotherapeutics, Inc., where 2 analysts have rated the stock as Strong buy, 0 analysts have given a Buy signal, 0 said it’s a HOLD, and 0 analysts rated the stock as Sell. (These Recommendations are for the Current Month Only reported by Yahoo Finance.)

Atara Biotherapeutics, Inc. closed its last trading session at $14.02 with the gain of 1.36%. The Market Capitalization of the company stands at 796.33 Million. The Company has 52-week high of $43.94 and 52-week low of $10.38. The stock’s current distance from 20-Day Simple Moving Average (SMA20) is 7.48% where SMA50 and SMA200 are 6.93% and -36.47% respectively. The Company Touched its 52-Week High on 12/04/18 and 52-Week Low on 10/31/19.

The Relative Volume of the company is 0.92 and Average Volume (3 months) is 696.78 million. The company’s P/E (price to earnings) ratio is 0 and Forward P/E ratio of 0.

The company shows its Return on Assets (ROA) value of -86.3%. The Return on Equity (ROE) value stands at -99.7%. While it’s Return on Investment (ROI) value is 0%.

While looking at the Stock’s Performance, Atara Biotherapeutics, Inc. currently shows a Weekly Performance of 3.42%, where Monthly Performance is 30.49%, Quarterly performance is 5.26%, 6 Months performance is -39.07% and yearly performance percentage is -64.24%. Year to Date performance value (YTD perf) value is -59.1%. The Stock currently has a Weekly Volatility of 2.59% and Monthly Volatility of 5.35%.

CenturyLink, Inc. (CTL) will report its next earnings on Nov 06 AMC. The company reported the earnings of $0.31/Share in the last quarter where the estimated EPS by analysts was $0.33/share. The difference between the expected and actual EPS was $-0.02/share, which represents an Earnings surprise of -6.1%.

Many analysts are providing their Estimated Earnings analysis for CenturyLink, Inc. and for the current quarter 10 analysts have projected that the stock could give an Average Earnings estimate of $0.33/share. These analysts have also projected a Low Estimate of $0.3/share and a High Estimate of $0.36/share.

In case of Revenue Estimates, 12 analysts have provided their consensus Average Revenue Estimates for CenturyLink, Inc. as 5.55 Billion. According to these analysts, the Low Revenue Estimate for CenturyLink, Inc. is 5.48 Billion and the High Revenue Estimate is 5.64 Billion. The company had Year Ago Sales of 5.78 Billion.

These analysts also forecasted Growth Estimates for the Current Quarter for CTL to be -10.8%. They are projecting Next Quarter growth of 8.82%. For the next 5 years, CenturyLink, Inc. is expecting Growth of 8.11% per annum, whereas in the past 5 years the growth was 10.92% per annum.

Some buy side analysts are also providing their Analysis on CenturyLink, Inc., where 1 analysts have rated the stock as Strong buy, 1 analysts have given a Buy signal, 2 said it’s a HOLD, and 0 analysts rated the stock as Sell. (These Recommendations are for the Current Month Only reported by Yahoo Finance.)

CenturyLink, Inc. closed its last trading session at $14.55 with the loss of -0.41%. The Market Capitalization of the company stands at 15.82 Billion. The Company has 52-week high of $19.05 and 52-week low of $9.64. The stock’s current distance from 20-Day Simple Moving Average (SMA20) is 0.01% where SMA50 and SMA200 are 10% and 20.04% respectively. The Company Touched its 52-Week High on 12/03/18 and 52-Week Low on 05/23/19.

The Relative Volume of the company is 0.42 and Average Volume (3 months) is 12.32 million. The company’s P/E (price to earnings) ratio is 0 and Forward P/E ratio of 10.22.

The company shows its Return on Assets (ROA) value of -12%. The Return on Equity (ROE) value stands at -52.1%. While it’s Return on Investment (ROI) value is 0.9%.

While looking at the Stock’s Performance, CenturyLink, Inc. currently shows a Weekly Performance of -2.42%, where Monthly Performance is 12.41%, Quarterly performance is 27.33%, 6 Months performance is 40.14% and yearly performance percentage is -22.64%. Year to Date performance value (YTD perf) value is -4.36%. The Stock currently has a Weekly Volatility of 2.23% and Monthly Volatility of 3.12%.

SHARE